Workflow
可孚医疗收盘上涨1.01%,滚动市盈率25.63倍,总市值77.41亿元

Core Viewpoint - Cofoe Medical's stock closed at 37.02 yuan, with a rolling PE ratio of 25.63 times, and a total market value of 7.741 billion yuan, indicating a relatively lower valuation compared to the industry average [1][2]. Company Overview - Cofoe Medical specializes in the research, production, sales, and service of medical devices, with a diverse product range including blood glucose systems, blood pressure monitors, and various medical consumables [2]. - The company has received several accolades, including recognition as a potential brand in the Chinese retail pharmaceutical market for 2023-2024 and being listed among the key trademark protection catalog in Changsha [2]. Financial Performance - In the first quarter of 2025, Cofoe Medical reported revenue of 738 million yuan, a year-on-year decrease of 8.59%, and a net profit of 91.425 million yuan, down 9.68%, with a gross profit margin of 52.17% [2]. Industry Comparison - The average PE ratio for the medical device industry is 55.46 times, with a median of 37.74 times, positioning Cofoe Medical at the 51st rank within the industry [1][3]. - Cofoe Medical's PE ratio is significantly lower than the industry average, indicating potential undervaluation compared to peers [3].